ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 699936 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 699936; 2) Community: the network communities that were significantly associated with the response to NSC 699936; 3) Molecule: the relationships between components within communities and NSC 699936; 4) MDR: the compounds that were significantly associated with the NSC 699936.

NSC Compound Enrichment Correlation
NSC 734631 Null 0.0375780807984392 0.1506656
NSC 735403 Null 0.0375780807984392 0.29803992
NSC 736591 Null 0.0375780807984392 0.40861836
NSC 744989 7-methoxy-8-[(5-2-methoxy-4-[(E)-3-(2,4-dimethyl-3-quinolyl)-3-oxo-1-propenyl]phenoxybutyl)oxy]-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one 0.0375780807984392 0.35581328
NSC 750685 Null 0.0375780807984392 0.29734249
NSC 753790 6-Imino-1,2,3,4,8,9,10,11-octahydropyrido[1,2-a]pyrido[1',2',1,2]imidazo[5,4-f]benzimidazol-13-one 0.0375780807984392 -0.15125622
NSC 762008 Copper(II) complex with a thiosemicarbazone as a ligand 0.0375780807984392 0.55809637
NSC 298223 Antibiotic CC 1065 (9CI) 0.0399098711718627 0.036769791
NSC 34475 Androst-5-en-16.beta.-ol, 3.beta.-methoxy- (8CI) 0.0399098711718627 0.076084314
NSC 50273 Pyridine, 3-[[4-[bis(2-chloroethyl)amino]-2-methylbenzylidene]amino]- 0.0399098711718627 -0.0468117
Total:100  Current:80    [First] [Prev] [Next] [Last]